Comment on

• Evidence-based guideline: treatment of parenchymal neurocysticercosis [RETIRED]: report of the Guideline Development Subcommittee of the American Academy of Neurology.

  Baird RA, Wiebe S, Zunt JR, Halperin JJ, Gronseth G, Roos KL. Baird RA, et al. Neurology. 2013 Apr 9;80(15):1424-9. doi: 10.1212/WNL.0b013e31828c2f3e. Neurology. 2013. PMID: 23568997 Free PMC article.
• Evidence-based guideline: Treatment of parenchymal neurocysticercosis: report of the Guideline Development Subcommittee of the American Academy of Neurology.

  Burneo JG, Escalaya AL. Burneo JG, et al. Neurology. 2013 Oct 15;81(16):1474. doi: 10.1212/WNL.0b013e3182a7afaf. Neurology. 2013. PMID: 24127192 No abstract available.
• Evidence-based guideline: Treatment of parenchymal neurocysticercosis: report of the Guideline Development Subcommittee of the American Academy of Neurology.

  Gonzalez-Duarte A. Gonzalez-Duarte A. Neurology. 2013 Oct 15;81(16):1474-5. Neurology. 2013. PMID: 24278968 No abstract available.
• Evidence-based guideline: Treatment of parenchymal neurocysticercosis: report of the Guideline Development Subcommittee of the American Academy of Neurology.

  Sethi NK. Sethi NK. Neurology. 2013 Oct 15;81(16):1475-6. Neurology. 2013. PMID: 24278969 No abstract available.